Early immune therapy may tame rare eye disease

This study looks at whether starting strong immune-suppressing drugs early can help control Vogt-Koyanagi-Harada (VKH) disease, a rare condition that causes eye inflammation and vision loss. Researchers will treat 40 newly diagnosed patients with high-dose steroids and other immune-suppressing medicines, then track their eye health for at least a year using special tests. The goal is to see if early treatment can reduce disease activity and protect vision.